Introduction
============

Sleep disorders are generally associated with psychological, respiratory, urinary, rheumatic, or circulatory diseases. However, some of the presenting symptoms of eye disease, such as circadian misalignment, pain, and fear, could also be associated with sleep and psychiatric problems. For instance, circadian misalignment may develop in patients with glaucoma or cataracts, possibly leading to sleep disorders. Cataract is a light-deprivation disease, filtering the blue light that sensitizes intrinsically photosensitive retinal ganglion cells (ipRGCs).[@b1-ndt-11-889] Recent studies demonstrated that cataract patients with yellow nuclear opacities had sleep disorders that improved after surgery to replace the opacified crystalline lens with an intraocular lens (IOL).[@b2-ndt-11-889]--[@b4-ndt-11-889] Light therapy itself is also recognized as an effective intervention for circadian rhythm disorder, cognitive disorders, and depression in older adults.[@b5-ndt-11-889] Glaucoma has a fundamental etiology of programmed cell death of retinal ganglion cells (RGCs), and its subgroup ipRGC expresses a newly identified opsin (melanopsin) that modulates photosynchronization of the superior chiasmatic nucleus, the master clock in the body.[@b6-ndt-11-889]--[@b9-ndt-11-889]

Eye disorders with chronic pain or discomfort, such as dry eye, trichiasis/entropion, chronic conjunctivitis, blepharitis, and other inflammatory diseases of the lid, conjunctiva, or cornea, may also be associated with sleep and mood disorders, via the trigeminal pathway.[@b10-ndt-11-889] Retinal diseases and glaucoma cause the most fear of blindness in patients since they directly affect vision and are often characterized by asymptomatic onset and worsening that disturbs quality of life.[@b11-ndt-11-889],[@b12-ndt-11-889]

The purpose of this study was to investigate the prevalence of psychiatric problems in ophthalmic patients, in order to eventually provide better medical care for these patients. Therefore, we carried out a questionnaire-based survey in eye clinics to explore the prevalence of probable sleep and mood disorders.

Materials and methods
=====================

Six eye clinics in various practices and locations participated in this study. Institutional Review Board/Ethics Committee approval was obtained in each medical facility. Visitors to the eye clinics were invited to fill out questionnaires, which included the Pittsburgh Sleep Quality Index (PSQI)[@b13-ndt-11-889] and the Hospital Anxiety and Depression Scale (HADS).[@b14-ndt-11-889] Each questionnaire was self-administered during their visit and performed from January through March, 2014. Young participants below the age of 10 years were assisted by parents or guardians. The score for each scale was calculated according to separate algorithms, and the scores were then subject to analysis. The cutoff points for possible sleep and mood disorders were 5/6 for the PSQI and 9/10 for HADS, respectively. These questionnaires have been widely used for hospital-based surveys[@b3-ndt-11-889],[@b4-ndt-11-889],[@b15-ndt-11-889],[@b16-ndt-11-889] and are easy to answer, even by eye clinic visitors, because they do not contain difficult questions concerning severe psychiatric disease (eg, suicide and hallucination).

All outpatients were examined by board-certified ophthalmologists and certified orthoptists, and their diagnosis was classified as retina, glaucoma, cataract, IOL, dry eye, lid/conjunctiva, or health check, according to the physician's examination and the patient's primary problem. Our diagnostic criteria included the following: for retina, any vitreoretinal disease or symptom (eg, diabetic retinopathy, retinal detachment, and epiretinal membrane); for glaucoma, glaucomatous visual field loss, optic nerve abnormality, or elevated intraocular pressure requiring topical medication; for cataract, bilateral crystalline lens opacity accounting for subjective visual disturbance or decreased visual function; for IOL, bilateral pseudophakia more than 6 months after the second eye surgery; for dry eye, subjective or objective symptoms of the ocular surface requiring eye drops (eg, corneal epithelitis, corneal erosion, and symptoms such as dryness, pain, burning, and irritation); for lid/conjunctiva, chronic inflammatory lid or conjunctival disease (eg, conjunctivitis, chalazion, and blepharitis); and for healthy eyes, patients diagnosed with no clinically significant eye disease, including eye health checks and patients for the prescription of eyeglasses or contact lenses. There were some patients with multiple eye diseases, and these patients were classified into each diagnostic group.

Where appropriate, data are given as the mean ± standard deviation. The mean score and proportion of patients with high values for the HADS and PSQI scores in each diagnostic group were compared among diagnostic groups. To identify which prominent eye diseases were complicated with psychiatric problems (sleep and mood disorders) in eye clinic visitors, a regression analysis was carried out with PSQI and HADS scores as dependent variables, and demographic (sex and age) and diagnostic groups as independent variables. Since some patients had multiple diagnoses and overlapped in diagnostic groups, a regression analysis was performed for each diagnostic group, adjusted for age and sex, and the results were compared among diagnostic groups. We found both sleep and mood disorders dominated in patients with dry eye and calculated the proportion of patients complicated with dry eye in the other diagnostic groups, where the chi-square test was used for comparison between IOL and cataract, ie preoperative and postoperative patients. Visual acuity was converted into LogMAR. All analyses were performed using StatFlex (Atech, Osaka, Japan) and SPSS version 21 (SPSS Inc, Chicago, IL, USA), with *P*\<0.05 considered significant.

The research project conformed to the provisions of the 1995 Declaration of Helsinki (as revised in Edinburgh 2000).

Results
=======

A total of 1,000 eye clinic visitors participated in the study. After exclusion of patients not relevant to the present analysis, namely, children \<10 years (n=16) and patients diagnosed with healthy eyes (n=173), acute injury (n=40), or unilateral pseudophakia (n=41), 730 patients were analyzed. The distributions of diagnosis, mean age, sex, and best-corrected visual acuity are given in [Table 1](#t1-ndt-11-889){ref-type="table"}. Of all patients, 37.3% of patients were poor sleepers (PSQI ≥6), and 45.5% had possible mood disorders (HADS ≥10). Among the diagnostic groups, PSQI was the worst (highest) in the dry eye group ([Table 2](#t2-ndt-11-889){ref-type="table"} and [Figure 1](#f1-ndt-11-889){ref-type="fig"}). The HADS score was also the worst (highest) in the dry eye group ([Table 2](#t2-ndt-11-889){ref-type="table"} and [Figure 2](#f2-ndt-11-889){ref-type="fig"}). Regression analysis demonstrated age (*P*\<0.05) and the presence of dry eye (*P*\<0.05) were significantly correlated with PSQI and HADS ([Table 3](#t3-ndt-11-889){ref-type="table"}). The presence of cataracts and IOLs were inversely correlated with the HADS score.

Analysis of the PSQI subscales revealed more details about the sleep disorder of patients with dry eye, IOL, and cataract ([Table 4](#t4-ndt-11-889){ref-type="table"}). Patients with dry eye had the highest or second-highest PSQI scores for sleep duration, subjective sleep, and daytime dysfunction, while PSQI scores for sleep latency, sleep efficacy, sleep disturbances, and sleep medication were highest in patients in the cataract and IOL groups. HADS scores for anxiety and depression were highest or second-highest in the dry eye group, while glaucoma patients had the highest HADS score for depression. The proportion of cases complicated with dry eye was highest in the IOL and glaucoma groups ([Table 4](#t4-ndt-11-889){ref-type="table"}). The proportion of patients with dry eye in the IOL group was significantly higher than that in the cataract group (*P*\<0.001, chi-square test).

Discussion
==========

The present study ascertained the sleep and mood condition of general eye clinic visitors, and revealed that some ocular problems were significantly associated with sleep and/or mood status. The most remarkable finding was that patients with dry eye had the worst PSQI and HADS scores. Recent reports[@b17-ndt-11-889]--[@b19-ndt-11-889] described that dry eye is closely associated with depression or a deteriorated quality of life, resulting in considerable loss of productivity in the active working population. One potential etiology may be chronic stress due to the dry sensation or irritation of the ocular surface. It is notable that the scores for PSQI and HADS in the lid/conjunctiva group were not as high as those in the dry eye group despite both clinical entities having common subjective symptoms, such as irritation, pain, and discomfort. Trichiasis and entropion, classified in the lid/conjunctiva group, are typical diseases, presenting with chronic irritation and a foreign body sensation, but the patients with these conditions did not record high scores for HADS or PSQI (data not shown). Our speculation is that patients with lid and conjunctival diseases can recognize the cause and location of their symptoms, thus the treatment effect of procedures or medication is as expected. In contrast, dry eye patients may be frequently anxious about their eyes, since symptoms of dry eye are lifelong, with unknown origin, and can worsen anytime due to seasonal, environmental, or local/systemic conditions. As such, dry eye may cause a constant feeling of discomfort or distress that causes mood disorders, especially in aged patients, who are especially sensitive to negative feelings and feelings of helplessness. Blindness as an outcome of eye disease may cause affective disorders, while sleep disorders usually accompany mood disorders. This corresponds to the finding that both sleep and mood disorders dominated in patients with dry eye. However, further studies are warranted, as the cross-sectional study design and inclusion method of this survey did not allow the following questions to be answered: Is depression in these patients caused by severe dry eye? Is dry eye caused by depression and/or sleeping disorders? Is dry eye in these individuals secondary to antidepressant medications?

Investigators have repeatedly reported significant improvement in the sleep quality of patients after cataract surgery;[@b3-ndt-11-889],[@b4-ndt-11-889] however, surgical prognosis and the sustainability of sleep improvement after surgery were not determined in our study. The patients in the cataract group had minimal symptoms and mainly attended for a regular check-up, while the patients in the IOL group had their second eye surgery more than 6 months previously. Therefore, we could not evaluate the effect of surgery on sleep as in previous studies. However, Alexander et al[@b3-ndt-11-889] reported the improvement in sleep after cataract surgery was not sustained for 12 months in either clear or yellow IOL cases. Espindle et al[@b20-ndt-11-889] also described an improvement in the mental health score, using the 12-item Short Form Health Survey, but this was not sustained for 12 months. They speculated that the initial improvement might be transient due to a positive emotional state, better photo entrainment, and increased physical activity.

While there was a negative correlation of cataract and IOL with mood disorders, sleep disorders were prominent in patients with cataract and IOL, suggesting, in these groups at least, that sleep disorders are independent of mood disorders. Many older adults have comorbidities that affect sleep quality, including diabetes, brain disorders, cognitive disorders, and reduced endocrine function, as well as use of multiple medications. Their sleep disorder may recur after termination of a transient surgical effect. These patients had a stable condition and were robust enough to visit the eye clinic, compared with disabled older adults. The high prevalence (41%) of dry eye in IOL patients may be associated with their sleep disorder as well as older age. Exacerbation of dry eye after cataract surgery has been described.[@b21-ndt-11-889],[@b22-ndt-11-889] A long surgery time, the surgical device used for aspirating irrigating solutions on the ocular surface, and insufficient lid hygiene have been suggested as risk factors for dry eye shortly after cataract surgery;[@b21-ndt-11-889],[@b22-ndt-11-889] however, further investigation will be necessary to explore whether cataract surgery and IOL itself have any association with long-term ocular surface problems.

Glaucoma patients did not have remarkably poor sleep despite their restricted visual field and presumably damaged ipRGCs. Their HADS score for depression was high, and some patients may be irritated by the disease and chronic use of medication. The high prevalence of dry eye in these patients may be due to topical medication containing preservatives.[@b23-ndt-11-889],[@b24-ndt-11-889] The sleep of glaucoma patients should be further evaluated by comparison with control patients with a normal visual field, adjusted for the presence of dry eye, especially taking into consideration that glaucoma patients do not have poor sleep, although their scores for mood disorders are high. Retina patients had mild anxiety, probably because many of their visits were for postoperative care.

This study had some limitations. Consecutive cases were enrolled to avoid bias, and the whole sample was heterogeneous with respect to age and sex. While the project was exploratory research, the results for each diagnostic group need further evaluation to clarify the relationship between the psychiatric disorders and the ocular pathologies. A control group was not included as each diagnostic group had a different age and sex distribution. There is a correlational nature of the findings in the present study, and hypotheses of causality would require evaluations at different time points. Further studies should be conducted to disclose psychiatric problems in eye disease patients.

In conclusion, the prevalence of sleep and mood disorders was highest in patients with dry eye, with some of these patients showing clinically significant scores for PSQI and HADS. Comprehensive management of eye clinic visitors with psychiatric problems, such as the use of consultation-liaison psychiatry services, would contribute to better health care for these patients.
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![Proportion of patients with high values for the PSQI in each diagnostic group.\
**Notes:** A score of PSQI ≥8 indicates a clinically significant sleep disorder. The value for dry eye patients was the worst.\
**Abbreviations:** IOL, intraocular lens; PSQI, Pittsburgh Sleep Quality Index.](ndt-11-889Fig1){#f1-ndt-11-889}

![Proportion of patients with high values for the HADS in each diagnostic group.\
**Notes:** A score of HADS ≥20 indicates a clinically significant mood disorder. The value for dry eye patients was the worst.\
**Abbreviations:** HADS, Hospital Anxiety and Depression Scale; IOL, intraocular lens.](ndt-11-889Fig2){#f2-ndt-11-889}

###### 

Patient demographics and visual acuity

  Diagnostic group                                               Total       Retina      Glaucoma    IOL         Cataract    Dry eye      Lid/conjunctiva
  -------------------------------------------------------------- ----------- ----------- ----------- ----------- ----------- ------------ -----------------
  Number of patients[†](#tfn2-ndt-11-889){ref-type="table-fn"}   730         120         109         99          159         247          289
  \% female                                                      66.7        47.5        56.0        63.8        61.0        82.2         71.7
  Age (years)                                                    59.5±19.0   61.8±13.3   68.2±13.9   74.2±10.1   72.7±10.9   61.4±17.3    51.1±21.2
  Median                                                         64          64          70          77          74          65           54
  Range                                                          10--96      15--88      27--95      28--88      42--96      11--95       10--96
  LogMAR of worse eye                                            0.10±0.35   0.33±0.68   0.08±0.20   0.12±0.28   0.26±0.45   0.05±0.26    0.02±0.14
  LogMAR of better eye                                           0.00±0.10   0.00±0.14   0.00±0.11   0.02±0.11   0.07±0.12   −0.01±0.08   −0.01±0.08

**Notes:** Data are mean ± standard deviation unless otherwise indicated.

Some of the patients had multiple diagnoses and so the sum is greater than 730.

**Abbreviation:** IOL, intraocular lens.

###### 

Diagnostic group and psychiatric results

  Diagnostic group   PSQI score                                           PSQI ≥6 (%)                                       HADS score                                            HADS ≥10 (%)
  ------------------ ---------------------------------------------------- ------------------------------------------------- ----------------------------------------------------- -------------------------------------------------
  Retina             5.1±3.3                                              35.0                                              9.6±5.5                                               43.2[\*](#tfn5-ndt-11-889){ref-type="table-fn"}
  Glaucoma           5.0±3.1                                              34.9                                              9.8±6.6[\*](#tfn5-ndt-11-889){ref-type="table-fn"}    38.8
  IOL                5.3±3.3                                              38.8                                              8.0±5.3                                               28.4
  Cataract           5.4±3.2[\*](#tfn5-ndt-11-889){ref-type="table-fn"}   39.6[\*](#tfn5-ndt-11-889){ref-type="table-fn"}   9.2±5.7                                               36.9
  Dry eye            5.7±3.3[\*](#tfn5-ndt-11-889){ref-type="table-fn"}   42.1[\*](#tfn5-ndt-11-889){ref-type="table-fn"}   10.2±6.0[\*](#tfn5-ndt-11-889){ref-type="table-fn"}   43.5[\*](#tfn5-ndt-11-889){ref-type="table-fn"}
  Lid/conjunctiva    5.2±3.1                                              33.0                                              9.0±6.0                                               41.8
  All cases          5.3±3.1                                              37.3                                              9.2±6.2                                               45.5

**Notes:** Data are mean ± standard deviation unless otherwise indicated.

Highest and second-highest values for each parameter.

**Abbreviations:** HADS, Hospital Anxiety and Depression Scale; IOL, intraocular lens; PSQI, Pittsburgh Sleep Quality Index.

###### 

Regression analysis between diagnostic groups and parameters

  Diagnostic groups and parameters                PSQI    HADS                                                         
  ----------------------------------------------- ------- ---------------------------------------------------- ------- ----------------------------------------------------
  Retina                                          −0.01   0.75                                                 0.01    0.86
  Glaucoma                                        −0.04   0.35                                                 0.02    0.51
  IOL                                             −0.01   0.79                                                 −0.15   \<0.001[\*](#tfn8-ndt-11-889){ref-type="table-fn"}
  Cataract                                        0.02    0.56                                                 −0.05   0.01[\*](#tfn8-ndt-11-889){ref-type="table-fn"}
  Dry eye                                         0.08    0.03[\*](#tfn8-ndt-11-889){ref-type="table-fn"}      0.08    0.03[\*](#tfn8-ndt-11-889){ref-type="table-fn"}
  Lid/conjunctiva                                 −0.01   0.88                                                 −0.05   0.18
  Age                                             0.13    \<0.001[\*](#tfn8-ndt-11-889){ref-type="table-fn"}   0.08    0.04[\*](#tfn8-ndt-11-889){ref-type="table-fn"}
  Sex[†](#tfn7-ndt-11-889){ref-type="table-fn"}   −0.03   0.33                                                 0.04    0.27

**Notes:**

Male =1, female =0.

*P*\<0.05, Pearson product moment correlation. Adjusted for age and sex.

**Abbreviations:** HADS, Hospital Anxiety and Depression Scale; IOL, intraocular lens; PSQI, Pittsburgh Sleep Quality Index.

###### 

PSQI and HADS subscale scores for each diagnostic group

  Diagnostic group   PSQI                                                    HADS                                                    \% with dry eye                                                                                                                                                                                                                                                                                                                                                                                     
  ------------------ ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- --------------------------------------------------
  Retina             0.92±0.94                                               0.77±0.57                                               0.38±0.76                                               0.40±1.00                                               1.12±0.91                                               1.10±0.70[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   0.48±0.76[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   5.0±3.1[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   4.6±3.1                                               10.8
  Glaucoma           0.91±0.96                                               0.76±0.56                                               0.41±0.77                                               0.37±0.94                                               1.26±0.87[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   0.99±0.74                                               0.46±0.63                                               4.6±3.3                                               5.0±3.8[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   32.9[\*](#tfn11-ndt-11-889){ref-type="table-fn"}
  IOL                1.08±1.00[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   0.80±0.56[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   0.50±0.86[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   0.63±1.15[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   1.15±0.79                                               0.92±0.71                                               0.40±0.58                                               4.3±3.0                                               3.8±3.2                                               41.0[\*](#tfn11-ndt-11-889){ref-type="table-fn"}
  Cataract           1.08±0.94[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   0.91±0.50[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   0.41±0.72[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   0.57±1.14[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   1.07±0.83                                               0.98±0.68                                               0.40±0.64                                               4.4±3.0                                               4.8±3.4                                               22.6
  Dry eye            1.07±1.01                                               0.78±0.54                                               0.37±0.73                                               0.52±1.07                                               1.35±0.83[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   1.08±0.73[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   0.48±0.74[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   5.4±3.2[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   4.9±3.4[\*](#tfn11-ndt-11-889){ref-type="table-fn"}   --
  Lid/conjunctiva    1.00±0.96                                               0.74±0.55                                               0.36±0.76                                               0.36±0.90                                               1.19±0.88                                               1.06±0.71                                               0.47±0.70                                               4.8±3.4                                               4.1±3.3                                               20.1
  All cases          0.99±0.97                                               0.78±0.54                                               0.36±0.74                                               0.41±0.97                                               1.21±0.86                                               1.05±0.70                                               0.49±0.70                                               5.0±3.3                                               4.6±3.4                                               33.6

**Notes:** Data are mean ± standard deviation unless indicated otherwise.

Highest and second-highest values for each parameter.

**Abbreviations:** HADS, Hospital Anxiety and Depression Scale; IOL, intraocular lens; PSQI, Pittsburgh Sleep Quality Index.
